| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1350 | 1994 |
| ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 S Mandal, J Barnett, SE Brill, JS Brown, EK Denneny, SS Hare, ... Thorax 76 (4), 396-398, 2021 | 918 | 2021 |
| Lung cancer—where are we today? Current advances in staging and nonsurgical treatment SG Spiro, JC Porter American journal of respiratory and critical care medicine 166 (9), 1166-1196, 2002 | 523 | 2002 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 469 | 2021 |
| LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment A Smith, M Bracke, B Leitinger, JC Porter, N Hogg Journal of cell science 116 (15), 3123-3133, 2003 | 297 | 2003 |
| Integrins take partners: cross-talk between integrins and other membrane receptors JC Porter, N Hogg Trends in cell biology 8 (10), 390-396, 1998 | 297 | 1998 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 284 | 2022 |
| Mechanisms contributing to the activity of integrins on leukocytes N Hogg, R Henderson, B Leitinger, A McDowall, J Porter, P Stanley Immunological reviews 186 (1), 164-171, 2002 | 234 | 2002 |
| Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 221 | 2020 |
| Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19 ER Mann, M Menon, SB Knight, JE Konkel, C Jagger, TN Shaw, ... Science immunology 5 (51), eabd6197, 2020 | 212 | 2020 |
| Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis CWM Ong, PT Elkington, S Brilha, C Ugarte-Gil, MT Tome-Esteban, ... PLoS pathogens 11 (5), e1004917, 2015 | 206 | 2015 |
| Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters α4β1-and α5β1-mediated function JC Porter, N Hogg The Journal of cell biology 138 (6), 1437-1447, 1997 | 187 | 1997 |
| Combination of endobronchial ultrasound‐guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary … N Navani, HL Booth, G Kocjan, M Falzon, A Capitanio, JM Brown, ... Respirology 16 (3), 467-472, 2011 | 174 | 2011 |
| Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit JS Friedland, JC Porter, S Daryanani, JM Bland, NJ Screaton, MJJ Vesely, ... Critical care medicine 24 (11), 1775-1781, 1996 | 162 | 1996 |
| Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac … EC Wicks, LJ Menezes, A Barnes, SA Mohiddin, N Sekhri, JC Porter, ... European Heart Journal-Cardiovascular Imaging 19 (7), 757-767, 2018 | 140 | 2018 |
| Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials LA Saketkoo, S Mittoo, D Huscher, D Khanna, PF Dellaripa, O Distler, ... Thorax 69 (5), 436-444, 2014 | 134 | 2014 |
| Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities P Mehta, JC Porter, JJ Manson, JD Isaacs, PJM Openshaw, IB McInnes, ... The Lancet Respiratory Medicine 8 (8), 822-830, 2020 | 133 | 2020 |
| Update in diagnosis and management of interstitial lung disease TA Mikolasch, HS Garthwaite, JC Porter Clinical medicine 16 (6), s71-s78, 2016 | 130 | 2016 |
| The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment AC Duarte, JC Porter, MJ Leandro Rheumatology 58 (11), 2031-2038, 2019 | 126 | 2019 |
| Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion JC Porter, M Bracke, A Smith, D Davies, N Hogg The Journal of Immunology 168 (12), 6330-6335, 2002 | 114 | 2002 |
Ashley M GrovesProfessor of Nuclear Medicine, UCLVerified email at ucl.ac.uk
